Veradermics, Inc

MANE NYSE SEC CIK 1827635
Follow Veradermics Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$21M −4.5% vs same quarter last year
EPS, diluted −$0.50 +98.3% vs same quarter last year
Operating cash flow −$22.9M −20.7% vs same quarter last year
Operating income −$28.8M −41.4% vs same quarter last year
Net income by quarter
−$12.4M
−$15.6M
−$20.1M
−$21.8M
−$27.2M
−$23.5M
−$21M
Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing